Vinati Organics Ltd
Incorporated in 1989, Vinati Organics Ltd manufactures specialty organic intermediaries
and Monomers[1]
- Market Cap ₹ 19,558 Cr.
- Current Price ₹ 1,888
- High / Low ₹ 2,331 / 1,412
- Stock P/E 48.3
- Book Value ₹ 269
- Dividend Yield 0.37 %
- ROCE 20.2 %
- ROE 15.4 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 19.6%
Cons
- Stock is trading at 7.01 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
1,029 | 954 | 1,616 | 2,066 | 1,900 | 2,248 | |
614 | 601 | 1,180 | 1,493 | 1,429 | 1,667 | |
Operating Profit | 415 | 353 | 435 | 573 | 471 | 581 |
OPM % | 40% | 37% | 27% | 28% | 25% | 26% |
45 | 26 | 61 | 52 | 39 | 44 | |
Interest | 2 | 1 | 2 | 3 | 5 | 1 |
Depreciation | 33 | 43 | 45 | 59 | 73 | 89 |
Profit before tax | 425 | 335 | 449 | 563 | 432 | 536 |
Tax % | 21% | 20% | 23% | 26% | 25% | 24% |
334 | 269 | 347 | 419 | 323 | 405 | |
EPS in Rs | 32.48 | 26.20 | 33.72 | 40.78 | 31.15 | 39.09 |
Dividend Payout % | 17% | 23% | 19% | 17% | 22% | 19% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 12% |
TTM: | 18% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 4% |
3 Years: | 5% |
TTM: | 25% |
Stock Price CAGR | |
---|---|
10 Years: | 23% |
5 Years: | 13% |
3 Years: | -2% |
1 Year: | 2% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 16% |
Last Year: | 15% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | 1,269 | 1,533 | 1,818 | 2,203 | 2,451 | 2,783 |
0 | 2 | 18 | 35 | 5 | 63 | |
163 | 188 | 243 | 335 | 374 | 423 | |
Total Liabilities | 1,443 | 1,734 | 2,090 | 2,584 | 2,840 | 3,279 |
751 | 757 | 873 | 1,159 | 1,489 | 1,724 | |
CWIP | 31 | 56 | 51 | 242 | 249 | 438 |
Investments | 227 | 289 | 94 | 227 | 64 | 36 |
434 | 632 | 1,071 | 955 | 1,038 | 1,081 | |
Total Assets | 1,443 | 1,734 | 2,090 | 2,584 | 2,840 | 3,279 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
416 | 219 | 127 | 515 | 332 | 458 | |
-197 | -198 | -255 | -329 | -348 | -443 | |
-109 | -3 | -47 | -62 | -108 | -16 | |
Net Cash Flow | 109 | 18 | -175 | 124 | -125 | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 72 | 106 | 104 | 82 | 102 | 96 |
Inventory Days | 79 | 115 | 75 | 79 | 72 | 68 |
Days Payable | 47 | 63 | 46 | 41 | 36 | 45 |
Cash Conversion Cycle | 104 | 158 | 132 | 120 | 137 | 118 |
Working Capital Days | 97 | 138 | 141 | 113 | 142 | 127 |
ROCE % | 24% | 27% | 28% | 19% | 20% |
Documents
Announcements
-
Email Communication To Shareholders Regarding Dividend Taxation Provisions
2d - Communication on TDS on ₹7.50 final dividend for FY 2024-25 and document submission instructions.
-
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015, Regarding Additional Investment In Veeral Organics Pvt. Ltd., Wholly Owned Subsidiary Company.
21 May - Vinati Organics invests ₹41.02 Cr in wholly owned subsidiary Veeral Organics via rights issue.
-
Announcement Under Regulation 30 (LODR)-Earnings Call Transcript
20 May - Vinati Organics Q4 FY25: 18% revenue growth, INR400 Cr capex, ATBS capacity expansion, strong 3-year 20% CAGR outlook.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
19 May - Vinati Organics' Annual Secretarial Compliance Report confirms full regulatory compliance for FY ended March 31, 2025.
-
Interview Of Ms. Vinati Saraf Mutreja, MD & CEO With CNBC - TV18
19 May - CEO interview on Q4 and FY25 financial performance aired on CNBC-TV18.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
-
Financial Year 2012
from bse
Concalls
-
May 2025TranscriptPPTREC
-
Aug 2024TranscriptPPT
-
Aug 2024TranscriptPPT
-
May 2024TranscriptPPTREC
-
Feb 2024TranscriptPPTREC
-
Aug 2023TranscriptPPT
-
Feb 2021TranscriptPPT
-
Aug 2018TranscriptPPT
Product Offerings
The company’s product portfolio includes over 30 products across: [1]